|
|
Volumn 12, Issue 6, 2008, Pages 393-398
|
|
Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROTRANSMITTER UPTAKE INHIBITOR;
PLACEBO;
FIBROMYALGIA;
HUMAN;
METHODOLOGY;
MOOD DISORDER;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SLEEP DISORDER;
TREATMENT OUTCOME;
FIBROMYALGIA;
HUMANS;
MOOD DISORDERS;
NEUROTRANSMITTER UPTAKE INHIBITORS;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SLEEP DISORDERS;
TREATMENT OUTCOME;
|
|
EID: 65249121996
PISSN: None
EISSN: 15343081
Source Type: Journal
DOI: 10.1007/s11916-008-0067-5 Document Type: Review |
|
Times cited : (8)
|
|
References (47)
|
